China SXT Pharmaceuticals Inc (SXTC)
0.43
-0.03
(-6.54%)
USD |
NASDAQ |
Nov 14, 16:00
0.43
0.00 (0.00%)
After-Hours: 20:00
China SXT Pharmaceuticals Shareholders Equity (Quarterly): 13.93M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 13.93M |
September 30, 2023 | 5.076M |
September 30, 2023 | 5.076M |
March 31, 2023 | 14.69M |
September 30, 2022 | 14.89M |
September 30, 2022 | 14.89M |
March 31, 2022 | 16.42M |
September 30, 2021 | 13.79M |
September 30, 2021 | 13.79M |
March 31, 2021 | 15.96M |
Date | Value |
---|---|
September 30, 2020 | 18.52M |
September 30, 2020 | 18.52M |
March 31, 2020 | 9.401M |
September 30, 2019 | 11.41M |
September 30, 2019 | 11.41M |
March 31, 2019 | 11.11M |
September 30, 2018 | 3.960M |
September 30, 2018 | 3.960M |
March 31, 2018 | 3.286M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.076M
Minimum
Sep 2023
18.52M
Maximum
Sep 2020
13.46M
Average
14.69M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.649B |
CASI Pharmaceuticals Inc | 9.021M |
Zai Lab Ltd | 704.18M |
Adagene Inc | 56.59M |
LakeShore Biopharma Co Ltd | 76.35M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.13M |
Total Liabilities (Quarterly) | 9.197M |
Debt to Equity Ratio | 0.1731 |
Current Ratio | 1.599 |
Net Debt Paydown Yield | -10.78% |